About Raydiant Oximetry
Raydiant Oximetry is a private company based in San Ramon, California. It has reported $13,940,387 raised in seven offerings on Form D since April 2018. Its chief executive is Neil Ray.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 28, 2024 | Jun 11, 2024 | $4,316,115of $5.4M target | 32 | $134K | EquityRule 506(b) | Form D ↗ |
| Jul 28, 2021 | Jul 29, 2021 | $2,035,855of $5.1M target | 13 | $156K | EquityRule 506(b) | Form D ↗ |
| Feb 5, 2020 | Feb 20, 2020 | $50,000of $770K target | 1 | $50,000 | EquityRule 506(c) | Form D ↗ |
| Dec 9, 2019 | Dec 20, 2019 | $900,000of $2.0M target | 11 | $81,818 | EquityRule 506(b) | Form D ↗ |
| Jun 6, 2019 | Sep 17, 2019 | $3,165,000fully sold | 25 | $126K | Equity, Options, Securities on exerciseRule 506(c) | Form D ↗ |
| May 7, 2019 | May 20, 2019 | $2,480,417fully sold | 38 | $65,274 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Feb 27, 2018 | Apr 17, 2018amended Aug 22, 2018 | $993,000of $1.5M target | 12 | $82,750 | DebtRule 506(b) | Form D/A ↗2 earlier filings |
| Total, seven offerings | $13,940,387 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Raydiant Oximetry's Form D filed Jun 11, 2024.
DR
Debra Reisenthel
Director
EB
Elizabeth Bailey
Director
CM
Charles McDonald
Director
NR
Neil Ray
Chief Executive Officer and director
AT
Annie Theriault
Director
RD
Russ DeLonzor
Executive officer
Earlier filings also listed Terri Burke (director, last listed Jul 2021) and John Maroney (director, last listed Jul 2021).